Literature DB >> 33007186

Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.

Tina Dyer1,2, D Robert Siemens3,4, Pria Nippak2, Julien Meyer2, Christopher M Booth1,4.   

Abstract

Entities:  

Year:  2021        PMID： 33007186      PMCID： PMC8021414          DOI： 10.5489/cuaj.6856

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  9 in total

1.  Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.

Authors:  Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Journal:  Eur Urol       Date:  2006-06-08       Impact factor: 20.096

2.  Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Authors:  Girish S Kulkarni; Peter C Black; Srikala S Sridhar; Anil Kapoor; Alexandre R Zlotta; Bobby Shayegan; Ricardo A Rendon; Peter Chung; Theodorus van der Kwast; Nimira Alimohamed; Yves Fradet; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2019-01-31       Impact factor: 1.862

3.  Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.

Authors:  C M Booth; D R Siemens; G Li; Y Peng; W Kong; D M Berman; W J Mackillop
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-06-20       Impact factor: 4.126

4.  Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?

Authors:  Christopher M Booth; Safiya Karim; Kelly Brennan; David Robert Siemens; Yingwei Peng; William J Mackillop
Journal:  Urol Oncol       Date:  2017-12-15       Impact factor: 3.498

5.  The effects of stage divergence on survival after radical cystectomy for urothelial cancer.

Authors:  Brent K Hollenbeck; David C Miller; Rodney L Dunn; James E Montie; John T Wei
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

6.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.

Authors:  F Pagano; P Bassi; T P Galetti; A Meneghini; C Milani; W Artibani; A Garbeglio
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

8.  Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.

Authors:  Christopher M Booth; D Robert Siemens; Gavin Li; Yingwei Peng; Ian F Tannock; Weidong Kong; David M Berman; William J Mackillop
Journal:  Cancer       Date:  2014-04-14       Impact factor: 6.860

9.  Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.

Authors:  P R van Dijk; M Ploeg; K K H Aben; P C Weijerman; H F M Karthaus; J Th H van Berkel; A C Viddeleer; A Geboers; E van Boven; J A Witjes; L A L M Kiemeney
Journal:  ISRN Urol       Date:  2011-04-27
  9 in total
  1 in total

1.  Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.

Authors:  Hyun Hwan Sung; Hana Kim; Ryul Kim; Chan Kyo Kim; Ghee Young Kwon; Won Park; Wan Song; Byong Chang Jeong; Se Hoon Park
Journal:  Investig Clin Urol       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.